Search

everythinglearnresearchcommunity

for

Search:↓

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

CHOP chemotherapy causes many side effects but is generally well tolerated.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

The document explains various skin conditions and their treatments.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.

A woman with severe angioedema improved significantly after treatment with rituximab.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Juvenile dermatomyositis can worsen quickly and needs strong treatment.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.